Adage Capital Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,308,014
| Closed | -$349M | – | 1140 |
|
|
2022
Q3 | $349M | Sell |
2,308,014
-731,078
| -24% | -$111M | 0.87% | 10 |
|
|
2022
Q2 | $443M | Buy |
3,039,092
+2,849,092
| +1,500% | +$415M | 1.02% | 11 |
|
|
2022
Q1 | $22.5M | Buy |
190,000
+75,000
| +65% | +$8.89M | 0.04% | 420 |
|
|
2021
Q4 | $15.8M | Buy |
115,000
+55,000
| +92% | +$7.58M | 0.03% | 559 |
|
|
2021
Q3 | $8.34M | Buy |
+60,000
| New | +$8.34M | 0.02% | 746 |
|
|
2021
Q2 | – | Sell |
-70,000
| Closed | -$4.79M | – | 1172 |
|
|
2021
Q1 | $4.79M | Sell |
70,000
-80,000
| -53% | -$5.47M | 0.01% | 804 |
|
|
2020
Q4 | $12.9M | Sell |
150,000
-300,000
| -67% | -$25.7M | 0.03% | 534 |
|
|
2020
Q3 | $29.3M | Buy |
450,000
+250,000
| +125% | +$16.3M | 0.07% | 283 |
|
|
2020
Q2 | $14.6M | Buy |
200,000
+3,025
| +2% | +$221K | 0.04% | 463 |
|
|
2020
Q1 | $6.7M | Sell |
196,975
-703,025
| -78% | -$23.9M | 0.02% | 536 |
|
|
2019
Q4 | $49M | Sell |
900,000
-675,000
| -43% | -$36.7M | 0.12% | 207 |
|
|
2019
Q3 | $65.7M | Buy |
1,575,000
+300,000
| +24% | +$12.5M | 0.16% | 160 |
|
|
2019
Q2 | $55.8M | Buy |
1,275,000
+600,000
| +89% | +$26.3M | 0.14% | 192 |
|
|
2019
Q1 | $34.7M | Buy |
675,000
+175,000
| +35% | +$9.01M | 0.09% | 267 |
|
|
2018
Q4 | $18.5M | Buy |
+500,000
| New | +$18.5M | 0.05% | 355 |
|